Back to Market Feed

APTENSIO XR 15 MG CAPSULE

methylphenidate hydrochloride
$7.9647per EA
DEA Schedule CII

Strength

15 mg/1

NDC

42858040245

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

11/19/2025

Approval Type

New Drug (NDA)

FDA Application

NDA205831

On Market Since

4/17/2015

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.1%

3Y

-0.4%

5Y

-0.4%

All

-0.4%

Generic Alternatives

Save up to 67%

1 alternative • Same active ingredient

METHYLPHENIDATE ER 15 MG CAP
Generic
00591386219•Actavis Pharma, Inc.
$2.6482
Save 67%

Related Drugs

Same classification

EXCEDRIN EXTRA STRENGTH GELTAB
Brand
00067202124•Haleon US Holdings LLC
$0.1205
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200020•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200024•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200033•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200050•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200077•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200091•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE GELTAB
Brand
00067203520•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE CAPLET
Brand
00067203924•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE CAPLET
Brand
00067203933•Haleon US Holdings LLC
$0.1338
per EA